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Transcription factor genes governing pigment cell development that are associated with spotting mutations in mice
include members of several structural transcription factor classes but not members of the basic helix–loop–helix
(bHLH) class, important for neurogenesis and myogenesis. To determine the effects of bHLH factor expression on
pigment cell development, the neurogenic bHLH factor Mash1 was expressed early in pigment cell development in
transgenic mice from the dopachrome tautomerase (Dct) promoter. Dct:Mash1 transgenic founders exhibit variable
microphthalmia and patchy coat color hypopigmentation. Transgenic F1 mice exhibit microphthalmia with com-
plete coat color dilution. Marker analysis demonstrates that Mash1 expression in the retinal pigmented epithelium
(RPE) initiates neurogenesis in this cell layer, whereas expression in remaining neural crest-derived melanocytes
alters their differentiation, in part by profoundly downregulating expression of the p (pink-eyed dilution) gene,
while maintaining their cell fate. The effects of transcriptional perturbation of pigment cell precursors by Mash1
further highlight differences between pigment cells of distinct developmental origins, and suggest a mechanism for
the alteration of melanogenesis to result in marked coat color dilution.
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The development of both neural crest-derived pigment cells,
or melanocytes, and the pigment cells comprising the retinal
pigmented epithelium (RPE) of the eye is governed by the
activities of transcription factors of different structural class-
es. Central to the development of both types of pigment
cells is the basic helix–loop–helix leucine zipper (bHLH LZ)
transcription factor Mitf, which is required for the proper
survival and/or differentiation of the two pigment cell types
(Opdecamp et al, 1997; Nakayama et al, 1998; Goding,
2000; Hornyak et al, 2001). Murine mutants of Mitf, of which
24 have been described (Moore, 1995; Hallsson et al, 2000;
Mouse Genome Database, May 2004), exhibit a set of phe-
notypes variably affecting the pigmentary pattern and color
of the coat, as well as the structure of the eye. Mitf expres-
sion in vivo in a tissue-specific pattern is directed by four
distinct promoters, each encoding a different exon 1 to result
in four different isoforms: Mitf-A, Mitf-B, Mitf-H, and Mitf-M
(Udono et al, 2000). Functionally, Mitf-M appears critical
for promoting the development of neural crest-derived me-
lanocytes, whereas Mitf-A and/or Mitf-H are sufficient to
promote the development of the RPE (Yajima et al, 1999).
Mitf-M, the isoform expressed in neural crest-derived
melanocytes, can be regulated by the activity of a number
of transcription factors, including Pax3, Sox10, Tcf/Lef-1,
and CEBP (Bondurand et al, 2000; Dorsky et al, 2000; Go-
ding, 2000; Potterf et al, 2000). Pax3, a transcription factor
of the paired homeodomain class, and Sox10, a member of
the SRY/HMG-domain class, appear to play major devel-
opmental roles in the regulation of Mitf because of several
reasons: (1) mutations of these transcription factors result in
heterozygous murine phenotypes similar to phenotypes
exhibited by selected heterozygous Mitf mutants; (2) these
factors demonstrate overlapping expression patterns in
cells of the neural tube and neural crest during develop-
ment, with Pax3 expression most widespread in the dorsal
neural tube (Goulding et al, 1991) and Sox10 restricted to
neural crest derivative precursor cells (Southard-Smith et al,
1998; Paratore et al, 2001); (3) PAX3/Pax3 and SOX10/
Sox10 synergize to transactivate the promoter to high levels
of expression (Bondurand et al, 2000; Potterf et al, 2001);
and (4) the human homologs of these transcription factors,
when mutated, are responsible for various types of the con-
genital disorder of pigmentation Waardenburg syndrome,
with poliosis, depigmented patches, and heterochromia
irides as shared pigmentary features of the different types
(Read, 2000).
In the RPE, Mitf also has a critical function. Severe Mitf
mutants undergo RPE transdifferentiation with hyperprolif-
eration of that cell layer (Bumsted and Barnstable, 2000;
Nguyen and Arnheiter, 2000b). Neither Pax3 nor Sox10 are
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expressed in the embryonic RPE, suggesting that other
specific transcription factors yet to be defined are important
for the transactivation of the Mitf-A or Mitf-H promoters
required for Mitf expression in the RPE. Additional studies
suggest that extraocular mesenchyme, by producing an
activin-like signal, may play an important role in the induc-
tion of Mitf, as well as the RPE-specific markers Wnt13 and
MMP115, in embryonic eye (Fuhrmann et al, 2000).
One important class of transcription factors that has not
been implicated directly in pigment cell development is the
class of basic helix–loop–helix (bHLH) transcription factors,
which includes transcription factors such as the myogenic
factor MyoD and the Drosophila achaete-scute and atonal
homologs, the neurogenic factors Mash1/2 and Math/
neuroD/neurogenin, respectively, that are important in cell
fate determination and differentiation (Kageyama et al, 1997).
In vivo, the neurogenic factors act in both the central and
peripheral nervous systems to promote the development of
distinct subclasses of neurons. Collectively, they appear to
act to promote neurogenesis at the expense of gliogenesis
(Tomita et al, 2000), a cell fate that may otherwise be induced
by initiation of Notch signaling (Morrison et al, 2000).
In the two systems in which pigment cell development is
relevant, the neural crest and the RPE, neurogenic bHLH
factors appear to have similar roles. In the development of
the neural crest, Mash1 promotes the development of au-
tonomic neurons, whereas the neurogenins are important for
sensory neuron formation. In the retina, the earlier expressed
gene Math5 fosters generation of bipolar cells (Brown et al,
1998). Mash1, which is expressed later in retinal neurogen-
esis in only a fraction of the proliferative cell population
(Jasoni and Reh, 1996), and Math3 together may also pro-
mote bipolar cell development at the expense of formation
of Mu¨ller glia (Hatakeyama et al, 2001). In contrast, NeuroD
appears to promote development of rod photoreceptors
(Ahmad et al, 1998; Yan and Wang, 1998). In the nervous
system, the fact that ngn1 can inhibit the expression of the
GFAP promoter demonstrates the potential for a neurogenic
bHLH factor to act instructively to promote the development
of a particular lineage whereas repressing the expression of
a promoter for a differentiation of an alternative cell fate of a
common precursor (Sun et al, 2001). These considerations,
together with the notable absence of mutations in bHLH
transcription factors from the large series of murine coat
color mutants that have been collected over decades,
prompted us to investigate whether inducing expression of a
neurogenic bHLH factor in vivo in the pigment cell lineage
would alter pigment cell development or differentiation.
To explore further the determinants of pigment cell de-
velopment in vivo, and to examine the effects of forced ex-
pression of a member of the bHLH transcription factor class
early in pigment cell development, we have generated
transgenic mice expressing the neurogenic bHLH gene
Mash1 from the dopachrome tautomerase (Dct) promoter, a
promoter of a gene encoding a melanogenic enzyme, also
known as tyrosinase-related protein-2, that is expressed
early in the lineages of both neural crest-derived me-
lanocytes and RPE cells (Steel et al, 1992). Mash1 expres-
sion in neural crest-derived melanocytes does not cause a
uniform alteration in melanocytic cell fate, but instead alters
melanocytic differentiation to result in mice with significant
dilution of coat color. This is associated with a striking
downregulation of expression of the p gene, a pigment cell-
specific gene encoding a melanosomal membrane protein
implicated in the acidification of the melanosome (Puri et al,
2000), required for biosynthesis of eumelanin. In contrast,
Mash1 expression in presumptive RPE cells results in a
transient change of cell fate, with downregulation of RPE
markers and induction of expression of markers character-
istic of early neuroretinal differentiation. These results fur-
ther highlight differences between neural crest-derived
melanocytes and the pigment cells of the RPE, and em-
phasize the requirement for crucial regulation of transcrip-
tion factor expression to govern the development and
differentiation of these cell types.
Results
Transgene structure, phenotype, and expression pat-
tern To express Mash1 in pigment cell precursors, a trans-
gene was constructed consisting of a fragment of the
Mash1 gene containing the entire first exon and intron and
part of untranslated exon 2 driven by 3.2 kb of upstream
regulatory sequence of the Dct gene that is first expressed
early in pigment cell development (Steel et al, 1992) (Fig 1).
This segment of Dct upstream regulatory sequence has
been previously shown to result in lacZ expression in me-
lanocyte precursors beginning at E10 and in RPE precursor
cells at E9.5 (Mackenzie et al, 1997; Zhao and Overbeek,
1999; Hornyak et al, 2001; Potterf et al, 2001). A FLAG
octapeptide epitope tag was inserted C-terminal to the ATG
initiation codon of the Mash1 gene to differentiate trans-
gene-driven Mash1 expression from expression of the en-
dogenous product.
Because of the possibility that transgene expression
could result in pigmentary abnormalities in F0 founders,
microinjections were administered in a mixed B6D2 back-
ground that would yield pigmented progeny. Two sets of
microinjections administered into these zygotes yielded 18
transgenic founders. Seven of 18 founders had coat color
aberrations, varying in extent from small white spots on the
belly or head to mottled white patches involving greater
than 50% of the coat (Fig 2A,C,E). One of these founders
Figure1
Structure of dopachrome tautomerase (Dct):Mash1 transgene. A
3.24 kb region of Dct upstream regulatory sequence together with 148
bp of Dct 50 untranslated sequence, previously shown to drive expres-
sion of lacZ in neural crest-derived melanoblasts and retinal pigmented
epithelium precursor cells temporally consistent with expression of
endogenous Dct (Hornyak et al, 2001), was used to direct expression
of FLAG-tagged Mash1 in pigment cell precursors. The intron is the
Mash1 intron and is followed by a 50 fragment of the untranslated
Mash1 exon 2 and the bovine growth hormone polyadenylation
sequence.
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also had severe microphthalmia (Fig 2A), with another
transgenic founder from this set having no coat color ab-
erration, but exhibiting slight left eye microphthalmia.
Most (five of six) of the transgenic male founders exhib-
iting either partial coat hypopigmentation or microphthalmia
were fertile, yielding transgenic F1 that had generalized
coat hypopigmentation on a nonagouti background as well
as bilateral microphthalmia. Although only one of eight
phenotypic transgenic founders transmitted the transgenic
phenotype to F1 progeny at a frequency approaching 50%
(founder #3, Table I), in general, there was a correlation be-
tween the extent of coat involvement in the founder and
frequency of transgene transmission to F1 progeny. One
notable exception is founder #6, with no apparent coat
spotting and mild right microphthalmia, who nonetheless
yielded phenotypic transgenic progeny at a frequency of
10%. Table I summarizes the transgene transmission pat-
tern and phenotypes of F0 mice and their F1 progeny.
Transgenic F1 progeny identified by PCR were homoge-
neously hypopigmented (on a nonagouti genetic back-
ground) and featured severe microphthalmia, regardless of
the presence of microphthalmia in the respective F0 founder
(Fig 2B,D,F). They transmitted the transgene to F2 progeny
with the expected 50% transmission ratio. The hues of F1
progeny were consistent within individual transgenic lines,
but varied between transgenic lines ranging from a light
cream (Fig 2B) that gradually darkened to a yellowish hue
(Fig 2G) to a smoky gray (line #3, Fig 2F). Individual hairs
were similarly colored (Fig S1A,B), rather than consisting of
a mixture of pigmented and unpigmented hairs as seen in
patchwork mutant mice (Aubin-Houzelstein and Panthier,
1999). The yellow hue on the coat of older transgenic
Figure 2
Phenotypes of transgenic mice and
transgene expression. (A) Phenotype of
transgenic founder (F0) #1 with large
cream-colored head patch (arrowhead)
and truncal sash-like patch (arrow) with
borders sharply demarcated at midline
and bilateral microphthalmia. (B) Trans-
genic F1 (arrow) from a cross between F0
#1 (A) and black nonagouti mouse, show-
ing homogeneous cream pigmentation of
coat and bilateral microphthalmia, which
are also features of three transgenic F2
littermates derived from this F1. (C) Trans-
genic founder #3 with extensive cream-
colored patches on the head and trunk,
again showing midline demarcations (ar-
row) but with phenotypically normal eyes.
(D) Transgenic F1 progeny (arrow) of
founder #3, showing homogeneous coat
hypopigmentation, slightly darker than F1
and F2 progeny from founder #1 (B), and
bilateral microphthalmia in contrast to
wild-type littermate (arrowhead). (E) Trans-
genic founder #5 with cream-colored head
patch (arrow), truncal flecks (arrowheads),
and normophthalmia. (F) Two transgenic
F1 (arrowheads) from founder #5 (arrow),
showing a homogeneously smoky-gray
coat color and bilateral microphthalmia
compared with founder. (G) Ventral white
spot (arrowhead) and yellowish hue that
develop in older progeny of founder #1. (H)
Expression (arrow) of FLAG-Mash1 in
post-natal follicle. Expression was re-
vealed by DAB-NiCl2 immunohistochem-
istry following incubation with M2 anti-
FLAG and HRP-conjugated anti-mouse.
Scale bar: 50 mm (H).
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progeny derived from founder #1 revealed the presence of
ventral white spotting (Fig 2G).
The presence of pigment in the coat, even if diluted, of
hypopigmented transgenic progeny implied that at least
some melanocytes completed development successfully
during embryogenesis and were present and transcription-
ally active in hair follicles, even though their profile of gene
expression was likely to be altered because of transgene
expression. To confirm the presence of cells expressing the
Dct:Mash1 transgene in murine follicles, the M2 anti-FLAG
monoclonal antibody was used to detect the expression of
transgene-directed Mash1 in these structures. In vivo ex-
pression of the epitope-tagged transgene product was ev-
ident in post-natal day 6 (P6) hair follicles of transgenic
animals (Fig 2H) and in a subset of cells in the posterior
retina of embryonic eye at E11.5 (data not shown) corre-
sponding to the normal location of the RPE in unaffected
eyes during development. Although non-physiologic ex-
pression of the Dct:lacZ transgene in the embryonic optic
stalk has been described (Hornyak et al, 2001), we did not
observe Dct:Mash1 expression in the optic stalk in E10.5
and E11.5 mice (data not shown).
Embryonic development of melanocytes in Dct:Mash1
transgenic background The presence of transgene-ex-
pressing cells in hair follicles, together with the presence of
pigment in the coat, implied that functional melanocytes
were present in the follicles of post-natal transgenic mice.
The presence of ventral white spotting in the progeny of
founder #1, however, led us to investigate whether me-
lanocyte development as well as differentiation were altered
by expression of the transgene. In previous studies, the
presence of ventral white spotting in certain coat color mu-
tant heterozygotes has been associated with a reduced
number of melanoblasts during embryonic development
(Hornyak et al, 2001; Potterf et al, 2001).
To determine the effect of Dct:Mash1 transgene expres-
sion upon melanocyte development in vivo, Dct:Mash1
hemizygous males from line #1 were crossed with females
hemizygous for the Dct:lacZ transgene. Dct:lacZ transgenic
mice have been used (Mackenzie et al, 1997; Zhao and
Overbeek, 1999; Hornyak et al, 2001; Potterf et al, 2001) to
visualize melanoblasts in vivo during embryogenesis. Anal-
ysis of several different transgenic lines has confirmed the
co-expression of endogenous Dct (Zhao and Overbeek,
1999) and c-kit (Hornyak et al, 2001) in cells expressing
b-galactosidase present either in the dorsolateral pathway
of neural crest cell migration or in embryonic epidermis,
establishing the utility of Dct:lacZ transgene expression as a
marker of the embryonic melanoblast. Results of inter-
crosses revealed fewer melanoblasts in Dct:Mash1 trans-
genic embryos compared with non-transgenic littermates at
E12.5 (Fig 3A–D) and E15.5 (Fig 3E,F). Melanoblasts in
E17.5 Dct:Mash1 transgenic embryos, however, were
present in the basal epidermis and in nascent follicles at a
similar density as in wild-type littermates (Fig 3G,H). Ex-
amination of follicular melanocytes at P24 in hematoxylin
and eosin-stained sections (Fig 3I, J) and S-100-stained
sections (Fig S1C,D) revealed comparable numbers of
follicular melanocytes in wild-type and line #3 Dct:Mash1
transgenic mice at this stage as well.
The finding that there are fewer lacZ-expressing cells in
the characteristic location of melanoblasts in the Dct:Mash1
transgenic background at E12.5 and E15.5 could imply ei-
ther that there are fewer melanoblasts present at this stage
or that Mash1 expression exerts effects upon the Dct pro-
moter limiting the expression of the Dct:lacZ transgene at
these stages. In fact, we did notice that the reaction time
course with the chromogenic substrate was delayed in
Dct:Mash1 transgenic embryos compared with wild-type
counterparts, suggesting that there was a lower concen-
tration of b-galactosidase in these cells that could result
from a negative effect of Mash1 upon Dct promoter-driven
gene expression. But the lengthy time course of the
chromogenic reactions, combined with the observation that
melanoblast numbers in E17.5 skin between Dct:Mash1 and
wild-type embryos are quite comparable, more likely signi-
fies that expression of the transgene in an early melanoblast
population results in a transient depletion in the melanoblast
population that is normalized following melanoblast entry
into the epidermis and follicular localization.
Altered expression of melanogenic genes in Dct:Mash1
transgenic mice The coat color dilution observed in
transgenic F1 progeny of the five founders that yielded
transgenic progeny, although variable, nonetheless suggested
Table I. Dct:Mash1 transgenic founders, phenotypes, and mosaicism







#1 Large cream-colored patches; severe microphthalmia M 7/86 8
#2 (417) Small cream head spot M 1/39 3
#3 (423) Extensive and mottled cream patches M 30/61 49
#4 (687) Small cream head spot M 0/19 0
#5 (692) Small cream flecks and head spot M 21/74 28
#6 (664) Mild microphthalmia right eye M 4/39 10
#7 (673) Belly spot and splotchy tail F No progeny
#8 (708) White patch on head F 0/28 0
Dct, dopachrome tautomerase.
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that the expression of melanogenic genes in follicular
melanocytes was altered. To determine potential alterations
in gene expression responsible for the coat color dilution,
we used RT-PCR (Halaban et al, 1996) to examine the rel-
ative expression of a set of melanogenic genes, Tyr, Tyrp1,
Dct, p, and Pmel17, in transgenic and wild-type dorsal
mouse skin using mice from line #1 that exhibited the most
profound coat color dilution. Results of these semi-quan-
titative experiments (Fig 4A) revealed that expression of the
p gene, encoding an integral melanosomal membrane pro-
tein that functions to acidify the melanosome (Puri et al,
2000), was undetectable in line #1 Dct:Mash1 skin, and that
levels of expression of both Tyrp1 and Dct are diminished.
Levels of p were also diminished, although not as much, in
mice of transgenic line #3 (Table I, Fig 2C,D) in which me-
lanogenic enzyme gene expression was determined quan-
titatively using real-time PCR. Interestingly, we observed a
doublet in the Tyrp1 amplicons, similar to that observed
previously in a mouse melanocyte cell line stably trans-
fected to express a low level of E1A (Halaban et al, 1996).
This may signify the presence of an alternatively spliced
form between exons 2 and 3, the locations of the amplifying
primers (see Supplementary Information). We did not ob-
serve significant differences using this method in expression
Figure 3
Melanoblast numbers throughout em-
bryogenesis in dopachrome tautom-
erase (Dct):Mash1 and wild-type
embryos. (A) E12.5, wild type (wt). Indi-
vidual b-galactosidase-expressing melano-
blasts (arrowheads) are present in the
periocular area of the cephalic region.
(B) E12.5, Dct:Mash1 transgenic (tg). Few
faintly staining melanoblasts (arrowheads)
are observed around the less intensely
staining optic cup. (C) E12.5, wt. Numer-
ous melanoblasts (arrows) are observed
lateral to the caudal neural tube at the
level of the hindlimbs. (D) E12.5, tg. A few
melanoblasts (arrows) are observed in
comparable location. (E) E15.5, wt. Nu-
merous melanoblasts are observed in the
cephalic region of this wild-type embryo.
(F) E15.5, tg. Substantially fewer individ-
ual melanoblasts are observed in the ce-
phalic region, with expression in the optic
cup only present in discrete foci (arrow-
heads). (G) E17.5, wt. Expression of trans-
gene in both epidermal (arrowheads) and
follicular (arrows) melanoblasts at this
stage of development. (H) E17.5, tg. Sim-
ilar density and localization of epidermal
(arrowheads) and follicular (arrows) melano-
blasts in transgenic skin compared with
wild-type skin at this stage of develop-
ment. (I) Follicular melanocytes with mel-
anin granules (arrow) in wild-type mice at
P24. (J) Follicular melanocytes and mela-
nin granules (arrow) in line #3 Dct:Mash1
transgenic mice at P24. Scale bar: 0.3 mm
(A, B), 0.1 mm (C, D), 0.6 mm (E, F),
0.2 mm (G, H), and 0.02 mm (I, J).
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of the tyrosinase gene or the pmel17 gene, the product of
the silver locus.
To provide added support that the partial effects ob-
served with Tyrp1 and Dct are transcriptionally mediated,
we performed co-transfection experiments in B16F1 mouse
melanoma cells to test whether Mash1 expression repress-
es transcription from the promoters of the melanogenic en-
zyme genes Tyr, Tyrp1, and Dct. Co-expression of Mash1
with Tyrp1 promoter and Dct promoter-lacZ constructs re-
sulted in as much as a 5-fold decrease in the activity of each
promoter with the highest amount of Mash1 expression
vector transfected (Fig 4D,E), although the negative effects
may be greater for Dct than for Tyrp1. Surprisingly, we ob-
served negative effects on a Tyr promoter construct similar
in magnitude to those observed with Tyrp1 and Dct (Fig 4F),
despite the fact that qualitatively less inhibition of Tyr was
observed in P2 skin homogenates (Fig 4A). The Tyr, Tyrp1,
Dct promoters contain an M-box, a conserved, 11-nucleo-
tide consensus sequence found in the proximal promoter
region of a set of melanogenic enzyme genes (Budd and
Jackson, 1995), that is recognized by Mitf, a bHLH LZ tran-
scription factor that has a central role in melanocyte devel-
opment and differentiation (Goding, 2000). Co-transfection
of a Mash1 expression vector with the concatemeric M-box
plasmid expression vector Mbpluc (Hemesath et al, 1994)
also resulted in significant transcriptional repression from
this artificial promoter (Fig 4G), showing that M box-de-
pendent transcription in melanocytes and melanoma cells is
capable of being repressed, either directly or indirectly, by
Mash1.
To further explore the differences between Tyr, Tyrp1,
and Dct expression levels and to resolve the discrepancy
between the minimal effects observed upon Tyr expression
in P2 skin and the significant repression observed in the
reporter gene experiment, we utilized quantitative real-time
RT-PCR to determine differences in expression between
wild-type and line #3 Dct:Mash1 transgenic mice in both P3
and P5 skin. The results of this experiment (Fig 4B,C) were
most consistent with the results of the semi-quantitative RT-
PCR experiment shown in Fig 4A. Greater decreases in
gene expression in Dct:Mash1 mice were observed for
Tyrp1 and Dct, at both P3 and P5, than for Tyr. The relative
Tyr expression was within 62% of the wild-type level in P5
Dct:Mash1 transgenic mouse skin (Fig 4C), a difference
within 1 standard deviation of the mean. Tyrp1 expression
was, however, only 7% of the wild-type level at this same
stage (Fig 4C). The significant differences between Tyrp1
and Dct expression, each compared with Tyr, in Dct:Mash1
post-natal mice, compared with the similar effects of Mash1
on all three promoters observed in the transfection exper-
iments, suggest that Mash1 alone may be insufficient in vivo
for repressing Tyr via the M box, either directly or indirectly.
Figure4
Expression and regulation of melanogenic genes in dopachrome
tautomerase (Dct):Mash1 transgenic mice. (A) RT-PCR analysis of
melanogenic gene expression in wild-type (wt) and Dct:Mash1
transgenic (tg) P2 mouse skin. Total RNA was isolated from individual
wild-type (#2, #4, #5) and transgenic (#7, #8, #9) pups, reverse-tran-
scribed, and amplified using PCR and primers to melanocyte-specific
(Tyr, Tyrp1, Dct, p, Pmel17) and control (b-actin, g3pdh) cDNA. PCR
reactions were performed for 30 cycles (Tyr, Tyrp1, Dct, p, Pmel17), 26
cycles (b-actin), and 20 cycles (g3pdh), respectively. (B, C) Real-time
RT-PCR analysis of melanogenic gene expression in P3 and P5 skin.
Relative expression levels of Tyr, Tyrp1, and Dct in Dct:Mash1
transgenic mouse skin were determined and normalized to the level
of expression observed in wild-type skin, which was arbitrarily assigned
a value of 1 for each gene analyzed at each time point. Data points for
each gene and genotype are presented as vertical boxes, with the
middle horizontal line representing the mean value for fold expression
and the upper and lower horizontal lines representing standard devi-
ations above and below the mean, respectively. (D) Transcriptional re-
pression of Tyrp1 by Mash1. B16F1 melanoma cells were transfected
with Tyrp1-lacZ reporter construct and empty vector or increasing
amounts of CMV/Mash1 expression vector. (E) Transcriptional repres-
sion of Dct by Mash1. Melan-a cells were transfected with Dct-lacZ
reporter construct and Mash1 expression vector as above. (F) Tran-
scriptional repression of Tyr by Mash1. B16F1 cells were transfected
with Tyr-luc reporter construct and Mash1 expression vector as above.
(G) Transcriptional repression of Mbpluc by Mash1. B16F1 cells were
transfected with concatameric M-box plasmid luciferase reporter
Mbpluc with empty vector or CMV/Mash1.
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Ocular development in Dct:Mash1 transgenic embryos
The microphthalmic phenotype of Dct:Mash1 transgenic
mice resembles the ocular phenotype observed in certain
members of the microphthalmia set of coat color alleles,
resulting from mutations in the Mitf gene, which is ex-
pressed strongly in RPE precursor cells in development
(Nakayama et al, 1998). Semidominant Mitf mutants have
severe microphthalmia when homozygous, with an accom-
panying thickening of sections of the RPE, diminished
expression of pigment cell marker genes (Nakayama et al,
1998), and induction of neuroretinal marker expression in
these sections with transdifferentiation into a second retina
(Bumsted and Barnstable, 2000; Nguyen and Arnheiter,
2000b). Endogenous Dct expression occurs as early as E9.5
in RPE precursor cells (Steel et al, 1992), and expression of
Dct:lacZ transgenes has been detected soon after this point
in development (Mackenzie et al, 1997; Zhao and Overbeek,
1999; Hornyak et al, 2001). The observation that the eyes of
E11.5 Dct:Mash1 transgenic embryos lacked visible pig-
mentation (Fig 5A,B) suggested that the RPE layer of the
developing retina was altered by expression of the trans-
gene. Like severe homozygous Mitf mutants, transgenic
RPE at E11.5, including the RPE of both line #1 (Fig 5D,F)
and line #3 (Fig 5E) that were examined, showed a stratified
layer of cells, largely devoid of visible pigment granules, in
the normal location of unaltered RPE. This was in contrast
to wild-type embryonic littermates that feature a single layer
of pigmented, cuboidal epithelium (Fig 5C).
The appearance of a stratified layer suggested that the
proliferative rate might be greater in transgenic RPE. We
utilized the proliferation marker Ki-67 to compare the pro-
liferation rate of wild-type and line #3 Dct:Mash1 RPE at
E11.5. The configuration of RPE cells rendered it difficult
to quantify results. Ki-67þ nuclei in both wild-type and
transgenic RPE were present singly and in small contiguous
groups of cells, in contrast to the more widely distributed
Figure 5
Retinal pigmented epithelium (RPE)
phenotype in dopachrome tautom-
erase (Dct):Mash1 transgenic mice.
(A, B) Whole-mount photomicrographs of
E11.5 embryos demonstrating pigmented
optic cup in wild-type embryo (arrow-
head, A) and non-pigmented optic cup in
transgenic littermate (arrowhead, B). (C,
D) RPE in wild-type and transgenic E11.5
embryos. Wild-type embryo shows nor-
mal RPE with a single layer of cuboidal
cells (C, rpe, arrowhead) posterior to neu-
ral retina (nr) and lens vesicle (lv), whereas
transgenic RPE (D, rpe, arrowhead) is
stratified and thickened. (E) RPE in line #3
Dct:Mash1 E11.5 transgenic embryo. RPE
(arrowhead) is a stratified epithelium
similar to the RPE observed in line #1
transgenic embryo (D). (F) RPE in line #1
Dct:Mash1 E11.5 transgenic embryo.
Higher magnification view of region of
RPE (arrowhead) from (D). (G, H) Ki-67
immunostain of wild-type (G) and trans-
genic (H) E11.5 RPE. Individual Ki-67þ
nuclei are observed individually and in
small groups in wild-type RPE cells and in
transgenic RPE cells (arrowheads, G, H),
but not as frequently as in the proliferative
neuroretina (nr). Scale bar: 0.8 mm (A, B),
0.06 mm (E, G, H), 0.05 mm (C, D), and
0.03 mm (F).
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pattern of Ki-67þ nuclei in the adjacent neural retina
(Fig 5G,H). The restricted pattern of Ki-67þ nuclei resem-
bles the restricted areas of BrdU reactivity in transdifferen-
tiating avian RPE expressing constitutively active MEK
(Galy et al, 2002). Although observations of different sec-
tions suggested that Ki-67þ might be more frequent in
Dct:Mash1 embryonic RPE compared with wild–type ones,
it would be difficult on the basis of this evidence to con-
clude definitively that the RPE alterations observed in
Dct:Mash1 transgenic embryos are associated with a higher
rate of cell proliferation. Little evidence of apoptosis was
observed, using both the TUNEL assay and anti-phospho-
histone H2B, in E11.5 wild-type or Dct:Mash1 RPE (data not
shown).
To determine whether, as in severe Mitf homozygous
mutants, RPE cells transdifferentiated as a result of Mash1
expression, further characterization of these cells was per-
formed to determine whether expression of neuroretinal
markers could be detected and whether characteristic pig-
ment cell markers were downregulated. We used the mono-
clonal antibody TuJ-1, reactive to a neuron-specific form of
b-tubulin (Easter et al, 1993) that is expressed by retinal
ganglion cells early in their development (Snow and Rob-
son, 1994; McCabe et al, 1999), and an antibody recogniz-
ing the neuroretinal transcription factor Chx10 (Liu et al,
1994) to determine whether altered RPE cells undergo ne-
uroretinal differentiation in this cell layer in line #1 transgenic
embryos. In contrast to the wild-type RPE, which did not
express TuJ-1 antigen (Fig 6A), TuJ-1 antigen expression
was observed in all quadrants of the transgenic RPE in the
E15.5 embryonic sections that we examined (Fig 6B). Chx10
expression was also observed in transgenic (Fig 6D), but
not wild-type (Fig 6C), RPE at E15.5. In both transgenic
embryos examined at this stage, however, Chx10 expres-
sion was limited to regions of the anterotemporal retina
(Fig 5D,E).
The RPE markers Mitf and Dct are expressed sequentially
early in RPE development (Hodgkinson et al, 1993; Naka-
yama et al, 1998). Both are markers of early RPE develop-
ment and are downregulated with RPE transdifferentiation
that occurs either upon introduction of fibroblast growth
Figure6
Expression of neuroretinal and retinal pigmented epithelium (RPE)
markers in wild-type and dopachrome tautomerase (Dct):Mash1
transgenic eyes. (A, B) TuJ-1 immunoreactivity in E15.5 wild-type and
transgenic eyes. Cryosections from wild-type (A) and transgenic (B)
mouse embryos were observed for immunofluorescence following in-
cubation with TuJ-1 monoclonal antibody and Alexa Fluor 488-conju-
gated secondary antibody. TuJ-1 immunoreactivity is limited to the
anterior neural retina (nr) and optic nerve (on), but not present in the
thin, pigmented RPE (arrowheads) in wild-type eye (A). In contrast, TuJ-
1 expression is observed both in the neural retina (nr) and in the non-
pigmented RPE (arrowheads) layer of transgenic eye (B). (C, D, E)
Chx10 immunoreactivity in E15.5 wild-type and transgenic eyes. Chx10
immunoreactivity is limited to the posterior neural retina (nr) in wild-type
eye (C) and is not observed in the RPE layer (between arrowheads).
Chx10 expression is, however, present both in the neural retina (nr) and
anterotemporal region of RPE layer (arrowheads) in transgenic eye (D).
The figure in (E) shows a higher magnification view of the delineated
region in (D), demonstrating the nuclear pattern of Chx10 expression in
the anterotemporal RPE layer of transgenic eye. (F, G) Mitf expression in
optic cup of E13.5 wild-type and transgenic eyes. Wild-type eye (F)
shows homogeneous expression of Mitf in optic cup by whole-mount in
situ hybridization. Transgenic eye (G) shows patchy expression of Mitf,
with large regions (arrowheads) of optic cup devoid of expression. (H, I)
Dct expression in the optic cup of E13.5 wild-type and transgenic eyes.
Wild-type eye (H) shows homogeneous expression of Dct. Transgenic
eye (I) shows absence of Dct expression in comparable location. (J)
Wild-type eye at E17.5. RPE layer (rpe) noted with arrow. (K) Dct:Mash1
(line #3) eye at E17.5, with the boxed area indicating the non-pigment-
ed section of RPE. (L) Dct:Mash1 (line #3) eye at P3, with the boxed
area indicating a non-pigmented RPE. (M) Higher magnification image
of the non-pigmented region of P3 RPE, demonstrating pigmented RPE
(rpe, arrow), transitional zone (tz), neuroretina-like non-pigmented RPE
(nr-like, arrow), and adjacent neuroretina (nr). Scale bar: 0.05 mm (E),
0.06 mm (L), 0.2 mm (A–D, I, J), 0.3 mm (F–I), and 0.5 mm (K).
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factor (FGF)-coated beads proximal to the developing eye
in explant cultures (Nguyen and Arnheiter, 2000b) or in the
Gas1 knockout mouse (Lee et al, 2001). The results of
whole-mount in situ hybridization experiments with E13.5
wild-type and transgenic embryos using antisense ribo-
probe to Dct, the later expressed marker, revealed virtually
no expression of Dct in transgenic embryos (Fig 6I) com-
pared with wild-type optic cups at this stage (Fig 6H) and at
E11.5 (data not shown). Expression of Mitf, normally ex-
pressed earlier than Dct, was also significantly disrupted in
the RPE of Dct:Mash1 embryos. All optic cups examined at
E13.5 (n¼6) featured large patches of weak or absent Mitf
expression (Fig 6G) that were not observed in wild-type
optic cups that expressed Mitf uniformly at this stage
(Fig 6F). For these studies, Dct:Mash1 mice from line #1
were backcrossed to albino FVB/N mice for five genera-
tions. In situ hybridizations performed on E11.5 and E13.5
wild-type FVB/N embryos using these markers revealed
homogeneous expression of Dct and Mitf (Fig S2), showing
that retinal degeneration reported with FVB/N mice (Park
et al, 2004) was not responsible for the differences ob-
served in the Dct:Mash1 transgenic background. The down-
regulation of Dct and Mitf expression in transgenic RPE,
together with the induction of Chx10 and neuron-specific
class III b-tubulin expression in this cell layer, supports the
notion that presumptive RPE cells begin to transdifferentiate
in Dct:Mash1 transgenic embryos. This failure of proper
RPE formation, required for normal development of the eye
(Raymond and Jackson, 1995), is likely to be the cause of
microphthalmia in Dct:Mash1 mice.
We wondered whether RPE differentiation observed in
line #1 during the E11.5–E15.5 time period was indicative
of changes leading to development of a full, multi-layered
second retina, as has been reported with Dct:FGF9
transgenic mice (Zhao and Overbeek, 1999); whether small-
er sections of the RPE would exhibit prolonged differenti-
ation as neural retina, as has been reported with Mitf mutant
mice (Nguyen and Arnheiter, 2000a); or whether transdiffer-
entiation was entirely transient, indicating a delay in normal
RPE development rather than a permanent change in
cell fate. We obtained histologic sections from line #3
Dct:Mash1 mice, which also exhibited early RPE stratifica-
tion (Fig 5E) and microphthalmia (Fig 2D), at E17.5 and P3 to
determine this. At E17.5, the majority of the RPE cells were
pigmented, similar to the RPE cells of a wild-type littermate
(Fig 6J), although a section of the RPE was thicker and
unpigmented and the overall shape of the eye was distorted
(Fig 6K). An unpigmented, thicker section of RPE was also
present in P3 Dct:Mash1 transgenic pups (Fig 6L). Upon
closer examination, the boundary between the pigmented
cells and the expanded section contained a transitional
zone between the pigmented RPE cells and the expanded
section. The morphology of the cells of the expanded sec-
tion resembled that of cells in the adjacent neuroretina.
These results suggest that Mash1 expression in RPE initi-
ates transdifferentiation to neuroretina, but that transdiffer-
entiation can be either transient or permanent, depending
upon regional factors. Differences in the level of expression
of the Dct:Mash1 between line #1 and line #3 may also be
responsible for variations in the extent of RPE transdiffer-
entiation.
Discussion
Transgene expression pattern of Dct:Mash1 transgene
in vivo The transgene expression pattern observed in F1
and later-generation embryos and pups, with evidence of
transgene expression in embryonic RPE precursors and in
follicular melanoblasts and melanocytes, is consistent with
the pattern of expression of the Dct:lacZ transgene that
used a similar promoter (Mackenzie et al, 1997; Zhao and
Overbeek, 1999; Hornyak et al, 2001). Expression of Dct-
driven Mash1 in embryonic and post-natal hair follicles and
in RPE at E11.5 is concordant both with Dct:lacZ transgene
expression and with the endogenous pattern of Dct
expression in vivo. Dct expression has been noted in the
forebrain, specifically the dorsal telencephalon, during
embryonic development (Steel et al, 1992; Hornyak et al,
2001). We did not observe any apparent differences in fore-
brain size or structure at these developmental stages
(Fig 5A,B, and data not shown).
Melanocyte development in Dct:Mash1 transgenic back-
ground The diminished number of Dctþ melanoblasts ob-
served in Dct:Mash1 transgenic embryos at E12.5 and
E15.5 relative to wild-type embryos (Fig 3) contrasts sharply
with the equivalent numbers of epidermal and follicular cells
present by E17.5. One possible reason for the early de-
crease in number is repression of Dct:lacZ expression by
Mash1, as Mash1 was demonstrated to have a negative
regulatory effect on Dct expression in vitro and in vivo
(Fig 4). But since the loss of Dct expression appears to be
relative and not absolute, and since the X-gal staining re-
actions are likely to represent enzymatic reactions taken
nearly to completion, it is unlikely that transcriptional re-
pression of the Dct:lacZ transgene reporter is the reason for
the reduction in the number of Dctþ cells at these earlier
stages of melanocyte development. Incidentally, the same
negative regulatory activity of Mash1 upon Dct could also
cause repression of Dct:Mash1 transgene expression. But if
repression resulted in the periodic abrogation of transgene
function, at least in adult hair follicle melanocytes, we may
have expected to observe banded, rather than homogene-
ous dilution of, hair color in these mice.
The absence of Dctþ cells at E12.5 with their presence
in reduced numbers at E15.5 suggests that transgene
expression delays differentiation of melanocyte progeni-
tors. We cannot rule out the possibility, however, that
transgene expression redirects a subset of these cells to
another cell fate or causes apoptosis in the dorsolateral
pathway. The similarity in the number and distribution of
melanoblasts at E17.5 between the wild-type and trans-
genic backgrounds suggests that enhanced melanoblast
proliferation or enhanced recruitment of precursor cells to
the melanocyte lineage occurs in the transgenic back-
ground between E15.5 and E17.5. A ‘‘late wave’’ of melano-
blast migration, recruitment, or proliferation has been
described in both rump-white and patch mice that have on-
ly a small number of melanoblasts at E15.5 that are signif-
icantly increased at E16.5 (Jordan and Jackson, 2000). A
similar mechanism may be responsible for the selective
apparent increase in melanoblast number that we observe
in Dct:Mash1 embryos between E15.5 and E17.5. Also,
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mice heterozygous for the Mitf mi allele have also been
shown to have a paucity of Dctþ cells at E15.5 (Hornyak
et al, 2001), and yet have a coat color pattern in the adult
that is nearly completely pigmented. These observations
support the existence of a ‘‘late wave’’ of melanoblast
migration, recruitment, or proliferation (Jordan and Jackson,
2000) in embryos lacking sufficient melanoblasts after
epidermal entry to populate each nascent follicle. The
consistent observation of a late wave of melanoblast
appearance in distinct strains of mutant mice may in-
dicate the existence of a mechanism ensuring that a
sufficient number of follicles are populated by melanoblasts
to yield homogeneous coat pigmentation in the adult
mouse.
Melanogenic gene expression in transgenic back-
ground The diluted coat color of Dct:Mash1 transgenic
mice, which varies from a smoky gray to cream depending
upon the transgenic line (Fig 1), implies that Mash1 expres-
sion in follicular melanocytes induced changes in me-
lanogenic gene expression accounting for the dilution of the
coat color phenotype. Indeed, we found that p expression
was undetectable in the skin of line #1 neonatal pups, and
that both Tyrp1 and Dct expression were diminished in the
skin of line #1 and line #3 Dct:Mash1 neonatal pups. The
color of Pink-eyed dilution (p) mice are a dull or light gray
(Russell, 1949; Brilliant and Gardner, 2001), which is the
same color as slaty mice with a mutation in Dct (Tsukamoto
et al, 1992; Budd and Jackson, 1995). Mutations in Tyrp1
result in mice with a brown coat color (Shibahara et al, 1986;
Jackson, 1988). Hence, it is unlikely that the reduction in
expression of any single one of these genes can account for
the more extensive coat color dilutions of the transgenic
lines we characterized. Complete loss of expression of p,
combined with relative decreases in the expression of Tyrp1
and Dct, may result in a more diluted coat color phenotype
than is obtained upon the loss of p expression itself. De-
creased expression of other melanogenic genes not exam-
ined may further exacerbate the degree of coat color
dilution caused by the loss of p expression alone in these
mice.
Mash1 has previously been shown to recognize the
muscle creatine kinase E box, CACCTG, in the context of a
heterodimer with the ubiquitous bHLH transcription factor
E12 (Johnson et al, 1992). This sequence differs from the
analogous hexanucleotide consensus sequence, CATGTG,
found in the M box conserved in the Tyr, Tyrp1, and Dct
promoters (Budd and Jackson, 1995) and bound by Mitf
(Hemesath et al, 1994; Bertolotto et al, 1998). Hence,
Mash1 may not exercise its negative regulatory activities on
Tyrp1 and Dct by directly binding to their promoter regions,
but may work indirectly by affecting the expression or ac-
tivity of other transcription factors interacting directly with
melanogenic gene promoters. Forced expression of Mash1
in melanocytes in vivo may mimic the activity of the bHLH
factor ITF2, which is more highly expressed in pheomela-
nogenic melanocytes compared with eumelanogenic me-
lanocytes (Furumura et al, 1998), to result in the repression
of certain melanogenic genes, thereby causing a partial
switch from eumelanogenesis to pheomelanogenesis within
the differentiated melanocyte.
RPE differentiation with induced Mash1 expression The
transdifferentiation of presumptive RPE cells observed in
Dct:Mash1 transgenic embryos is similar to that observed in
murine embryos carrying mutations in the Mitf gene (Nguyen
and Arnheiter, 2000b) and embryos expressing FGF9 from
the Dct promoter (Zhao and Overbeek, 1999). Micro-
phthalmia and RPE disruption have also been described
in murine embryos expressing either Ret (Schmidt et al,
1999) or a dominant-negative FGF receptor (Rousseau et al,
2000) in the RPE from the Tyrp1 promoter. Loss of expres-
sion of the growth arrest-specific gene 1 (gas1) has also
been shown to cause RPE transdifferentiation, specifically
of the ventral RPE, in rodent embryos (Lee et al, 2001).
Experiments with avian embryos have shown that retrovi-
rally directed expression of activated MAPK/ERK kinase
(MEK-1) can induce transdifferentiation of RPE (Galy et al,
2002), and overexpression of both neuroD (Yan and Wang,
1998) and neurogenin2 (ngn2) (Yan et al, 2001) transcription
factors can promote the development of retinal neurons
from avian RPE cells maintained in culture. Our work sug-
gests that expression of a similar neurogenic bHLH factor in
rodent embryonic RPE in vivo induces neuronal differenti-
ation as well. This could occur through one of two mech-
anisms: (1) the intrinsic neurogenic activity of Mash1 or (2)
less specifically by triggering the default, neurogenic fate of
these cells observed in the absence of Mitf (Nguyen and
Arnheiter, 2000a).
One unresolved question about RPE cells is the degree
to which they retain competence to transdifferentiate as a
function of developmental stage. For example, in an avian
study, post-natal RPE cells maintained in the ciliary body
that retain expression of the transcription factor genes mitf
and pax6 have been shown to be competent in undergoing
initial transdifferentiation events upon exposure to insulin
and FGF2 (Fischer and Reh, 2001). Our results demonstrate
that, in vivo, competence of rodent RPE to transdifferentiate
is maintained beyond the stage of initial expression of Mitf in
presumptive RPE cells to the stage at which Dct is ex-
pressed. Mitf expression has been shown to precede ex-
pression of Dct in neural crest-derived melanoblasts by 4–6
h and to precede Dct in RPE development as well (Naka-
yama et al, 1998). The expression of Mash1 induced by
activation of the Dct promoter should be delayed in
transgenic embryos until after initial expression of Mitf, with
endogenous Dct expression also initiated at the time of in-
itial Mash1 expression. The data showing evidence of gene
expression in embryonic eye in Figs 3 and 6 are consistent
with this interpretation. Figure 6G shows that some cells
in transgenic embryos are Mitfþ while others are not,
whereas the overall level of Dct expression in transgenic
embryos is insignificant in Fig 6I. The images of X-gal-
stained eyes of E12.5 and E15.5 transgenic embryos in Fig
3B,D, however, show regions and clusters of transgene
expression in the eye. This may be explained by the obser-
vation that, in direct comparison, detection of the Dct:lacZ
transgene is more sensitive than detection of Dct message
by in situ hybridization (Zhao and Overbeek, 1999). Addi-
tionally, the distribution of foci of Mitf expression through
regions of the RPE in the E13.5 optic cup (Fig 6G) suggests
that generation of RPE precursor cells is not limited to
one area of the optic cup at this stage of development,
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consistent with the observation of multiple dispersed foci of
lacZ expression seen at the same developmental stage in
Fig 3D. The finding that the majority of the RPE at E17.5 and
P3 in line #3 transgenic animals (Fig 5K, L) is pigmented
suggests that the foci of Mitf expression at E13.5 (Fig 6G)
and Dct:lacZ expression at E15.5 (Fig 3F) represent re-
sumption of RPE differentiation following a transdifferenti-
ation-associated delay induced by Mash1 expression, or
may reflect differences in transgene expression between
line #1 and line #3.
The behavior of pigment cells in Dct:Mash1 transgenic
mice further highlights differences between neural crest-
derived melanocytes and RPE cells. During development,
neural crest-derived melanoblasts are either transiently de-
pleted or undergo a delay of differentiation. But they sub-
sequently expand in number to populate most or all of the
coat. The major effect of Mash1 is upon their differentiation
state, by decreasing expression of certain melanogenic
genes. In contrast, RPE precursors hyperproliferate and
transdifferentiate upon transgene expression, leading to
structural changes that result in microphthalmia. The
persistence of neuroretinal-like cells in early post-natal
Dct:Mash1 mice suggests that the cell fate of RPE precur-
sors may be more sensitive to the effects of the Dct:Mash1
transgene. The changes in pigment cell function and fate
that result from the ectopic expression of a single bHLH
transcription factor underscore the sensitivity of these cells
to transcriptional perturbation at early points in their devel-
opment and differentiation.
Materials and Methods
Generation, characterization, and maintenance of Dct:Mash1
transgenic mice The transgene was excised from the plasmid
pPDct/FLAG-Mash1 via an SpeI/SmaI double digest. Plasmid
pPDct/FLAG-Mash1 was generated by inserting the fragment
FLAG-Mash1 into the XhoI site of the plasmid pPDct (Hornyak et al,
2000). The fragment FLAG-Mash1 was generated from a mouse
Mash1 genomic clone template (Guillemot et al, 1993) using over-
lap extension PCR (Ho et al, 1989) with the proofreading thermo-
stable polymerase Pfu to insert the 24 bp nucleotide sequence
encoding the DYKDDDDK FLAG octapeptide sequence into the
coding region of the Mash1 gene immediately downstream of the
N-terminal methionine ATG codon. It comprised sequences be-
ginning with the proximal 90 bp of 50 untranslated sequence
(Verma-Kurvari et al, 1996), the entire exon 1 and intron, and the 50
48 bp of exon 2 (Franco del Amo et al, 1993). The correct sequence
of the PCR-generated fragment was confirmed by dideoxy se-
quencing. The fragment is followed by the bovine growth hormone
polyadenylation sequence (pA) from plasmid pcDNA3 (Invitrogen,
Carlsbad, California).
Two sets of microinjections were administered into zygotes re-
sulting from B6D2F1 male and female matings. Mice were obtained
from Taconic (Germantown, New York) for the first set of microin-
jections and from The Jackson Laboratories (Bar Harbor, Maine) for
the second set of microinjections. Founders were characterized by
PCR analysis of tail DNA isolates and by inspection of coat color and
ocular phenotypes. For detection of the transgene, tail or yolk
sac DNA was amplified with forward primer 50-AGATCTCGAG-
TTTGATCGTGCTTCGCAGCC-30 and reverse primer 50-AAA-
GAAGCAGGCTGCGGGAG-30 flanking the FLAG epitope tag
oligonucleotide sequence. This amplified a 152 bp fragment in
wild-type mice and an additional 176 bp band in transgenic mice
identifiable as a higher mobility band on a 2% agarose gel.
Transgenic animal and embryo identification was confirmed by the
presence of a higher mobility product corresponding to the presence
of the FLAG sequence in the Mash1 gene. All animal studies were
performed under animal protocols approved by either the Henry
Ford Health System Institutional Animal Care and Use Committee or
the National Cancer Institute Animal Care and Use Committee.
Cell culture and transfections B16F1 mouse melanoma cells
(American Type Culture Collection, Manassas, Virginia) were main-
tained at 10% CO2, 371C, 10% FCS/DMEM for transfection stud-
ies. Cells were transfected using Lipofectamine (Invitrogen) with 1
mg of RSV/luc (with lacZ-containing experimental reporter vectors)
or CMV/lacZ as internal control, 2 mg of either a CMV promoter-
containing empty vector (pcDNA3, Invitrogen) or CMV/FLAG-
Mash1, and 1 mg of experimental reporter vector. Luciferase ac-
tivity of transfected cell lysates was quantified in a Berthold Lumat
luminometer (Berthold Technologies, Bad Wildbad, Germany), and
results were normalized to b-galactosidase activity as measured by
the ONPG assay or by b-galactosidase-induced chemilumines-
cence (Tropix, Bedford, Massachusetts).
b-galactosidase activity staining, immunohistochemistry, and
immunoﬂuorescence studies For b-galactosidase activity stain-
ing, embryos were harvested from pregnant females at 12, 15, or
17 d after detection of the vaginal plug. The morning of plug de-
tection was regarded as E0.5. Observed developmental stage cor-
responded to expected stage by morphological criteria (Kaufman
and Baird, 1999). E12.5 and E15.5 embryos were dissected and
fixed overnight in 0.4% paraformaldehyde in PBS. X-gal staining
was performed overnight as well until color reaction was complete.
Embryos were subsequently post-fixed in 4% paraformaldehyde in
PBS and stored in 50% glycerol/PBS. For E17.5 embryos, sections
of dorsal skin were removed from embryos prior to fixation, and
fixed alone in 0.4% paraformaldehyde. This permitted penetration
of X-gal staining solution to the follicles to permit adequate
follicular staining. Ten micrometer sections were subsequently cut
for comparative description and analysis.
For detecting the expression of the transgene product in P6
follicles, sections of skin from the midline upper back of P6 pups
were cryosectioned and incubated with biotinylated M2 anti-FLAG
monoclonal antibody (Sigma, St Louis, Missouri) followed by
Vectastain ABC Elite Kit (Vector Labs, Burlingame, California) and
DAB-NiCl2. Ocular cryosections were treated similarly for detecting
transgene expression in embryonic eye.
Immunohistochemical staining with anti-Ki-67 and anti-S-100
antibodies was performed with 1:1000 rabbit polyclonal anti-Ki67
(NCL-Ki67p, Novocastra Laboratories, Newcastle upon Tyne, UK)
and 1:100 rabbit polyclonal anti-S-100 (Sigma). Immunohisto-
chemistry was performed on paraffin-embedded sections of
mouse embryos and skin following antigen retrieval by boiling par-
affin sections in 10 mM citrate, pH 6.0, for 4 min in a microwave
pressure cooker. HRP-conjugated anti-rabbit and DAB were used
according to the manufacturer’s protocol (Cell and Tissue Staining
Kit, R&D Systems, Minneapolis, Minnesota) for color development.
Immunofluorescence studies were performed using cryosec-
tions from the eyes of E15.5 mice and the skin of E17.5 mice. For
detection of b-tubulin, 10 mm sections were cut and fixed with
100% methanol at 201C for 15 min, followed by 4% paraformal-
dehyde in PBS for 2 min at room temperature. Sections were in-
cubated overnight with a 1:500 dilution of TuJ-1 monoclonal
antibody (Covance, Richmond, California), washed, and incubated
with 1:500 Alexa Fluor 488 goat anti-mouse (Molecular Probes,
Invitrogen Detection Technologies, Carlsbad, California) for 1 h. For
detection of Chx10, sections were fixed in 3.7% paraformalde-
hyde/0.3% Triton X-100 in PBS at room temperature for 5 min.
Blocking was carried out with 0.3% Triton X-100/1% BSA in PBS
for 1 h, 2% goat serum/1% BSA for 1 h, and 7.5% goat serum/1%
BSA in PBS for 1 h. Sections were incubated with 1:50 dilution of
polyclonal anti-Chx10 (a gift from R. McInnes) in 0.1% goat serum/
1% BSA in PBS overnight, washed in PBS, and incubated with
1:500 dilution of Alexa Fluor 546 goat anti-rabbit (Molecular
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Probes, Invitrogen Detection Technologies) for 1 h. Sections were
viewed on a Leica DMIRB inverted microscope with appropriate
filters and photographed using Ektachrome 400 film (Kodak,
Rochester, New York) under identical conditions of time and filters
when comparing wild-type and transgenic specimens for a given
antibody.
Whole-mount in situ hybridizations Antisense riboprobes to Mitf
and Dct were generated from the plasmids mc1 (Hodgkinson et al,
1993) and p5A7 (Steel et al, 1992), respectively. Dct:Mash1
transgenic mice from founder #1 were backcrossed with FVB/N
females to place on an albino background to eliminate pigmenta-
tion in the RPE at the examined embryonic stages. Timed preg-
nancies were obtained from albino Dct:Mash1 males with FVB/N
females, and embryos were harvested in RNase-free PBS at E13.5.
Embryos fixed overnight in 4% paraformaldehyde in PBS were
subsequently treated for 30 min with 10 mg per mL Proteinase K in
PBTX (PBS/0.1% Triton X-100 pH 7.4) and refixed in 0.2% glutar-
aldehyde/4% paraformaldehyde in PBTX for 20 min prior to pre-
hybridization at 651C for 2 h and hybridization at 651C overnight. In
situ hybridizations with wild-type FVB/N embryos were performed
with Proteinase K digests of 15 and 25 min, respectively, for E11.5
and E13.5 embryos. Riboprobe concentrations were 1 mg per mL
for the Mitf riboprobe and 5 mg per mL for the Dct riboprobe.
Complete details are available upon request.
Semi-quantitative RT-PCR and quantitative real-time PCR anal-
ysis of gene expression in wild-type and Dct:Mash1 murine
skin For semi-quantitative RT-PCR (Fig 4A), skin from the dorsal
trunk was harvested from line #1 P2 pups immediately after sac-
rifice and homogenized in 3 mL TRIzol reagent (Invitrogen) using a
Polytron PT 1200 (Kinematica AG, Lucerne, Switzerland) until tis-
sue was completely emulsified. Total RNA was purified from TRIzol
solution following the manufacturer’s instructions. First-strand
cDNA synthesis was performed using the SuperScript First-Strand
Synthesis for RT-PCR System (Invitrogen) according to the man-
ufacturer’s instructions. Oligonucleotide primer sequences and
protocol for RT-PCR were as described (Halaban et al, 1996). Mul-
tiple cycle numbers were performed to ensure that the signals ob-
tained were within the linear range of amplification.
For real-time PCR, total RNA was isolated from six independent
dorsal skins (three wild-type, three Dct:Mash1 line #3 transgenic)
of P3 and P5 mice by homogenizing for 1 min in TRIzol LS reagent
with a Polytron following the manufacturer’s protocol (Invitrogen).
Transgenic status was confirmed by PCR analysis of tail DNA di-
gests. cDNA was synthesized from 1 mg of total RNA from P3 and
P5 samples using the Superscript First-Strand Synthesis System
for RT-PCR (Invitrogen). The RNA was treated with DNase prior to
cDNA synthesis according to the Superscript protocol. A PCR
mastermix consisting of, per 20 mL volume unit, 1.5  RT buffer
(Invitrogen), 1  SYBR Green 1 (Molecular Probes, Invitrogen De-
tection Technologies), 3 mM MgCl2, 1 mL ROX reference dye (In-
vitrogen), 5% DMSO, 0.2 mL Hot MasterTaq DNA Polymerase
(Eppendorf, Hamburg, Germany), and cDNA reverse transcribed
from 50 ng total RNA was prepared for each sample. Primer se-
quences based on GenBank accession numbers NM_011661 (Tyr),
NM_031202 (Tyrp1), NM_010024 (Dct), and NM_007393 (b-actin)
were designed using Primer Express (Applied Biosystems, Foster
City, California). The primers for Tyr, Tyrp1, Dct, and b-actin were
tested for primer–dimer formation prior to their use in real-time
PCR analysis. The final primer concentration was 0.3 mM. Reac-
tions in a total volume of 30 mL per tube were run for 40 cycles as
follows: 951C, 15 s; 601C, 1 min. Primer sequences, localization on
cDNA, and method of analysis are presented in Supplementary
Information.
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Figure S1 Hair and hair follicles of P24 wild-type and line #3
Dct:Mash1 transgenic mice. (A) Hair of P24 wild-type littermate of line
#3 Dct:Mash1 transgenic mouse. (B) Homogeneous dilution of coat
color in hair from P24 line #3 Dct:Mash1 transgenic mouse. (C, D)
Comparable S-100 immunoreactivity in the base of follicles of P24 wild-
type (C) and line #3 Dct:Mash1 transgenic (D) murine skin. Arrowheads
signify groups of S-100þ cells in the base of hair follicles. Scale
bar¼0.05 mm (C, D).
Figure S2 Dct and Mitf expression in FVB/N embryonic RPE. (A) Mitf
expression in RPE of E11.5 embryonic eye. (B) Dct expression in
RPE of E11.5 embryonic eye. (C) Dct expression in RPE of E13.5 embryo-
nic eye.
Supplemental text Real-time PCR primer sequences and results
analysis.
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